Condensed Consolidated Statements of Operations (Unaudited) (USD $) In Millions, except Per Share data, unless otherwise specified	3 Months Ended		9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Net sales	$ 1,846	$ 1,735	$ 5,493	$ 5,305
Cost of products sold	550	510	1,651	1,618
Gross profit	1,296	1,225	3,842	3,687
Operating expenses:
Selling, general and administrative expenses	741	658	2,150	1,950
Research and development expenses	212	217	609	644
Royalty expense	21	28	86	115
Amortization expense	109	101	327	305
Goodwill impairment charges	0	0	0	423
Intangible asset impairment charges	12	0	177	53
Contingent consideration expense (benefit)	(4)	23	(122)	(18)
Restructuring charges	2	19	37	55
Litigation-related charges (credits)	139	76	399	206
Gain on divestiture	0	0	(12)	(40)
Operating expenses	1,232	1,122	3,651	3,693
Operating income (loss)	64	103	191	(6)
Other (expense) income:
Interest expense	(54)	(137)	(161)	(266)
Other, net	(7)	(6)	15	(10)
Income (loss) before income taxes	3	(40)	45	(282)
Income tax expense (benefit)	(40)	(35)	(135)	(53)
Net income (loss)	$ 43	$ (5)	$ 180	$ (229)
Net income (loss) per common share — basic	$ 0.03	$ 0.00	$ 0.14	$ (0.17)
Net income (loss) per common share — assuming dilution	$ 0.03	$ 0.00	$ 0.13	$ (0.17)
Weighted-average shares outstanding
Basic	1,325.5	1,340.3	1,323.5	1,345.2
Assuming dilution	1,347.6	1,340.3	1,347.3	1,345.2